We investigated sodium and volume-dependent mechanisms in the modulation of adrenal and renal vascular responsiveness to angiotensin II in hypertensive (n = 9) and normal subjects (n ‫؍‬ 5) who demonstrated normal responses during steady-state salt balance (intact modulation). Adrenal and renal vascular responses to angiotensin II were assessed on four occasions. These studies were performed during steady-state high salt and low salt balance and later during non-steady state conditions, after acute volume expansion with normal saline or dextran infusions. The volume expansion studies were administered while study subjects were in low salt balance. In both the normal and hypertensive patients saline and dextran suppressed plasma renin activity and aldosterone release, induced renal vasodilation and enhanced the renal vascular response to angiotensin II, similar to that observed during high salt
Introduction
The renin-angiotensin-aldosterone system plays an important role in defending blood pressure and maintaining intravascular volume homeostasis. Acutely, angiotensin II (Ang II) affects the renal and peripheral vasculature and adrenal glomerulosa by reducing renal blood flow, enhancing vascular tone, and increasing aldosterone secretion.
1,2 All of these physiologic changes promote renal sodium conservation and maintenance of blood pressure.
In normal subjects and the majority of hypertensive patients changes in sodium intake produce reciprocal changes in vascular and adrenal responsiveness to Ang II. 2 However, most studies investigating control of the renin-angiotensinaldosterone system have been conducted during balanced, constant dietary salt intake. Free-living individuals often vary salt intake quite markedly balance. Saline also reduced the adrenal response to angiotensin II in normal subjects but the adrenal response to angiotensin II in hypertensives remained enhanced. The slopes of regression lines relating angiotensin II and aldosterone following saline infusion were significantly different (P Ͻ 0.05) between normal subjects (21 ؎ 6) and hypertensives (110 ؎ 33). Volume expansion with dextran did not effect the normal or hypertensive adrenal response to angiotensin II. We have demonstrated that the renal vascular response to angiotensin II is rapidly modulated by volume expansion per se in normal subjects and hypertensive patients with intact steady-state renin-angiotensin-aldosterone system responses. However, hypertensives have a delay in resetting the adrenal responsiveness to angiotensin II suggesting that they have altered sodium perception during rapid changes in salt balance.
from day-to-day. 3 Therefore, an important aspect of the regulation of the system is its ability to accommodate to short term fluctuations in dietary salt intake. How rapidly these adaptive responses occur affects how quickly the individual can adjust sodium excretion to intake.
This study was designed to explore the sodium and/or volume-dependent regulation of aldosterone production and the renal vasculature in normotensive and hypertensive patients during non-steadystate conditions. During the study we made the unanticipated observation that the group of hypertensive patients who have intact steady-state modulation of renal vascular and adrenal responsiveness respond differently than normal subjects. By stressing the renin-angiotensin system with sodium depletion followed by rapid volume expansion we have shown that these hypertensive patients actually have a delay in the resetting of Ang II responsiveness of the adrenal glomerulosa that is consistent with an alteration of sodium perception.
Subjects and methods

Study subjects
Nine patients with essential hypertension and five normotensive subjects were studied prospectively. Some results from the normotensive subjects have been previously reported. 4 All untreated hypertensive patients had blood pressure Ͼ140/90 mm Hg and those on antihypertensive medications had exceeded this level prior to initiation of therapy. Hypertensive patients were withdrawn from medication at least 3 weeks prior to enrolment in the study. The protocol was approved by the Human Subjects Committee of the Brigham and Women's Hospital and informed, written consent was obtained prior to participation.
All subjects consumed an isocaloric constant diet during the study. Study subjects initially consumed a 200 mmol sodium, 100 mmol potassium diet for the first 2 days and then their diet was changed to 10 mmol sodium, 100 mmol potassium which was continued for the duration of the study. Daily 24-h urine collections were assessed for sodium and creatinine excretion to document external sodium balance.
Based on studies described below all study participants had intact modulation of adrenal responsiveness to Ang II, defined as an increase in aldosterone with Ang II infusion (3 ng/kg/min) during low salt balance that is Ͼ420 pmol/L (15 ng/dL).
5
Acute volume expansion
After achieving low salt balance each subject received an infusion of normal saline or dextran-40 (Rheomacrodex, Pharmacia, Piscataway, NJ, USA) in random order to expand intravascular volume. Following a 5-6 day re-equilibration on the low salt diet the alternate infusion was administered. The first infusion was performed with subjects in the supine position beginning at 08.00 am on the day after low sodium balance had been achieved. The subjects were fasted overnight and during the infusions. Saline was administered at 500 ml/h for 4 h; dextran was infused at 250 ml/h and was accompanied by 250 ml/h 5% dextrose in water (D5W) for a total of 500 ml/h over 4 h. The amounts of infused saline and dextran were designed to achieve similar intravascular volume expansion. The smaller amount of dextran infused was chosen because dextran-induced intravascular volume expansion occurs, in part, by attracting fluid from extracellular and intracellular compartments and results in an approximate doubling of the infused volume. 6 The additional D5W was co-administered to avoid this potential interstitial and intracellular space volume contraction. Hematocrit, plasma renin activity (PRA), Ang II and aldosterone were measured at baseline and at the end of the infusions.
Renal vascular and adrenal responses to angiotensin II
To measure renal vascular and adrenal responses to Ang II, the subjects were infused with Ang II (3 ng/kg/min for 45 min) on four separate occasions: during high salt balance, after achieving low salt balance, 3 h following the saline infusion, and 3 h following the dextran infusion. On each occasion the subjects were supine from 12.30 pm and the Ang II infusion was begun 3 h later. Renal plasma flow was measured with para-aminohippurate (PAH, Merck, Rahway, NJ, USA) which was infused at 12 mg/min after an 8 mg/kg loading dose. The PAH infusion was begun 60 min prior to the Ang II infusion and was continued during the Ang II infusion. Blood samples were obtained for measurement of plasma aldosterone, PAH, PRA and Ang II at the beginning (−10 and 0 min) and end of the Ang II infusion.
Laboratory procedures
All blood samples were collected on ice and centrifuged at 4°C, and plasma was stored at −20°C until the time of assay. Aldosterone, PRA and immunoreactive Ang II were measured by RIA. Urinary electrolytes were measured with an ion-selective electrode system. Plasma and infusate PAH concentrations were measured by a Technicon autoanalyser spectrophotometer. Clearance of PAH corrected for body surface area was calculated as previously described. 
Statistical analysis
Mean values are presented with s.e.m. as the index of dispersion. Within group differences were tested for significance using the paired t-test or analysis of variance. Between group differences were assessed using the unpaired t-test. The Fisher exact test was used to compare non-homogeneously distributed data. Time dependent variables were evaluated using two-way repeated measures analysis of variance. Correlations of plasma Ang II and aldosterone levels were assessed using linear regression. Comparisons of the slopes from linear regressions of the Ang II/aldosterone relationships in normal and hypertensive subjects were compared using a Wilcoxon Rank Sum test. The null hypothesis was rejected at an ␣ level of Ͻ0.05.
Results
Renin-angiotensin system, renal and adrenal responses to volume expansion
The clinical characteristics of the study participants are shown in Table 1 . Low salt balance led to acti- vation of the renin-angiotensin-aldosterone system with significant increases in steady-state levels of PRA, Ang II and aldosterone (Table 2 ) and adrenal responsiveness to Ang II (Figure 1 ). The response to salt restriction in the hypertensive patients was indistinguishable from that in normal subjects. Rapid volume expansion with either saline or dextran infusion produced similar suppression of PRA and Ang II and similar haemodilution (as measured by haematocrit) (Table 3) confirming that comparable volume expansion had occurred with the two infusions. Both saline and dextran rapidly increased PAH clearance and reduced plasma aldosterone to levels seen during high salt balance (Figure 2 ).
Renal and adrenal responses to angiotensin II
Renal vascular and adrenal glomerulosa responsiveness to Ang II infusion were studied after each volume expansion manoeuver and compared to the responses during steady-state salt balance. Saline and dextran infusions during low salt balance enhanced the renal vascular responsiveness to Ang II (Figure 3 ). After each volume expansion manoeuver the renal blood flow response to Ang II was similar to that seen during high salt balance. This pattern was similar in both the hypertensive patients and normal subjects. Low salt diet significantly reduced renal blood flow and increased aldosterone levels when compared to high salt intake in both the normal subjects and hypertensive patients. Both saline and dextran infusions, administered during low salt balance, increased basal renal blood flow and reduced aldosterone to levels similar to high salt balance in both groups. *P Ͻ 0.05 vs HS (ANOVA).
The aldosterone response to Ang II infusion was more complex (Figure 4 ). Saline infusion rapidly modulated adrenal responsiveness to Ang II in normal subjects. This adrenal response to Ang II after saline was similar to high salt responsiveness. However, hypertensive patients retained enhanced adrenal responsiveness following saline infusion that was similar to the response during low salt balance. Additionally, the slopes of the regression lines relating Ang II and aldosterone following saline infusion were significantly different (P Ͻ 0.05) between hypertensives (110 Ϯ 33) and normal subjects (21 Ϯ 6).
Despite its modulating effect on the renal vasculature, dextran volume expansion did not affect adrenal responsiveness to Ang II. In the hypertensive patients the increment in aldosterone secretion in response to Ang II following dextran was similar to low salt balance (low salt: 660 Ϯ 100 pmol/L, dextran: 670 Ϯ 100 pmol/L) and was significantly different (P Ͻ 0.05) from high salt balance (470 Ϯ 70 pmol/L). This same pattern was also seen in the normal subjects whose aldosterone response following dextran (780 Ϯ 280 pmol/L) was similar to low salt balance (600 Ϯ 170 pmol/L). There was also no difference in the slopes of the regression lines relating Ang II and aldosterone between the groups following dextran infusion.
Urinary sodium excretion was measured during the 24 h following the saline and dextran infusions. The hypertensive patients excreted less sodium after both infusions (saline: 44 Ϯ 11 mmol Na + /24 h, dextran: 23 Ϯ 3 mmol Na + /24 h) than the normal subjects (saline: 50 Ϯ 12 mmol Na + /24 h, dextran: 30 Ϯ 8 mmol Na + /24 h) although these differences between groups were not significant.
Discussion
In this study we found that saline and dextran infusions suppressed the circulating renin-angiotensin system, increased basal renal plasma flow and enhanced renal vascular responsiveness to Ang II in sodium restricted normal subjects and hypertensive patients. These observations suggest that modulation of renal vascular responsiveness to Ang II is rapid and mediated by mechanisms that are volumesensitive per se, since both dextran and saline produced similar effects.
However, saline and dextran infusions dissociated the control of basal adrenal secretion from the determinants of its Ang II responsiveness. Volume expansion with both dextran and saline suppressed plasma aldosterone to levels similar to high salt balance. However, saline infusion also shifted adrenal responsiveness to Ang II in normal subjects but not in the hypertensives. Over the range of Ang II levels achieved during the Ang II infusion the relationship of aldosterone to infused Ang II became blunted after saline infusion in the normal subjects and was similar to high salt balance. In the hypertensives this relationship remained enhanced. The adrenal response to Ang II was unaffected by dextran in either the normal subjects or hypertensives. Therefore, this rapid modulation of adrenal responsiveness to Ang II in normal subjects is mediated by sodium-dependent mechanisms since saline but not dextran reversed the effects of low salt balance. This process was delayed in the hypertensive patients but the delay was clearly temporary since during steady-state conditions they demonstrated normal modulation.
What is not answered from these studies is how the state of sodium and volume is sensed and how does this signal reach the kidney and adrenal glomerulosa. For the renal vasculature there is reason to believe that the state of the renin-angiotensin system is important. Changes in ambient Ang II concentrations affect the response of the vasculature by influencing the density of Ang II receptors. 8 We found that both saline and dextran were effective in suppressing PRA. Thus, increasing intravascular volume per se with saline or dextran produced signals (either intra-renal or extra-renal) which influenced renin-angiotensin system activity and altered responsiveness of these target tissues to Ang II.
For modulation of adrenal responsiveness the sources of and types of signals generated in response to sodium or volume expansion must be considered more speculative. The results of this study support earlier findings showing that the renin-angiotensin system is probably not important in this modulation 705 process. 4, 9, 10 For example, treating sodium-restricted normal subjects with an angiotensin-converting enzyme inhibitor does not alter the adrenal response to exogenous or endogenous Ang II. 9, 10 Other potential candidates include contributions by atrial natriuretic hormone (ANH), dopamine, or digitalis-like factors. ANH levels vary directly with the state of sodium intake 11 and ANH infusion reduces PRA and aldosterone secretion, particularly in sodiumrestricted normal subjects. 12 Plasma and urinary dopamine increase with sodium loading and dopamine inhibits aldosterone secretion both in vivo and in vitro. [13] [14] [15] Levels of endogenous digitalis-like factors also increase during saline infusion 16 and ouabain inhibits aldosterone secretion in vitro. 17 Some or all of these factors may participate in the adrenal modulation induced by saline infusion. However, there is still much uncertainty about the physiology of this process.
The delayed modulation of adrenal responsiveness to Ang II observed in the hypertensive patients despite their intact steady-state responses may have functional implications. Studying the behaviour of renal vascular and adrenal responsiveness to Ang II under steady-state salt balance conditions is convenient for understanding underlying mechanisms but must be considered non-physiological. For most individuals dietary sodium intake fluctuates widely from day-to-day, largely because the sodium content of each meal tends to be capricious and food intake is discontinuous. Despite this, urinary sodium excretion is continuous and varies in relation to intake. As an example, epidemiologists have observed that estimates of average dietary sodium intake are best derived by measuring 24-h urine collections over many days rather than a single day. 3 The non-steady-state observations described in this study may be directly applicable to changes in renal and adrenal responsiveness to Ang II which occur on a daily basis. Our results show that large shifts in the state of sodium balance in normal subjects can produce normal modulation within hours. Also, for a given level of sodium intake and plasma Ang II level, hypertensive patients with intact modulation may carry slightly higher aldosterone levels and have the potential to retain more sodium when consuming a high salt diet. Coupled with the proposed extra-renal effects of aldosterone in promoting cardiac interstitial fibrosis 18 and left ventricular hypertrophy 19 the higher aldosterone levels may have other pathophysiologic consequences.
These findings provide evidence that hypertensive patients with intact modulation during steadystate dietary salt intake do not regulate target tissue responsiveness to Ang II as rapidly as normal subjects. The delay in modifying adrenal responsiveness to Ang II that is present in hypertensive patients with intact modulation suggests that their ability to perceive and respond to a sodium load is not normal. This may be due to abnormalities in the signals generated in response to increased sodium intake or in the manner in which target tissues respond to those signals.
